Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
APGE | Apogee Therapeutics, Inc. | Chief Executive Officer, Director | $80.3M | -$7.23M | -8.26% | Nov 6, 2024 |
ARYD | ARYA Sciences Acquisition Corp IV | Director | Jul 31, 2024 | |||
SYRE | Spyre Therapeutics, Inc. | Director | May 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|